Subclinical hypothyroidism during pregnancy and the impact of levothyroxine therapy on pregnancy outcomes in women
PeerJ · 2025
DOI: 10.7717/peerj.19343 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, 2025. Verfasst von Yutian Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Clinical Medical Sciences, The Fourth Hospital of Shijiazhuang, Shijiazhuang, China. Hauptthemen laut MEDLINE: Hypothyroidism, Thyroxine, Pregnancy Outcome, Pregnancy Complications. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aims
The purpose of this study is to investigate the impact of subclinical hypothyroidism (SCH) during pregnancy and levothyroxine (LT4) therapy on pregnancy outcomes.
Methods
Among 6,510 pregnant women who came to The Fourth Hospital of Shijiazhuang for pregnancy examination and delivery, 266 pregnant women with SCH and treated with LT4 were selected as the SCH group and 672 pregnant women without SCH were selected as the non-SCH group, and the incidence rates of adverse pregnancy outcomes in pregnant women and newborns of the two groups were compared using Chi-square test and logistic regression. According to the therapeutic effect, pregnant women treated with LT4 were categorized into sustained euthyroid status (SES) and suboptimal thyroid status (STS) groups and compared with the non-SCH group using chi-square test. The correlation of thyroid stimulating hormone (TSH) levels at different stages of pregnancy was explored using Spearman’s rank test.
Results
The incidence of hypertensive disorders of pregnancy (HDP), premature rupture of membranes (PROM), and neonatal outcomes were ventricular or atrial septal defect (V/ASD), hyperbilirubinemia, and pneumonia were higher in the SCH group (SCH pregnant women) than in the non-SCH group (non-SCH pregnant women) ( p < 0.05). The incidence of multiple maternal and neonatal complications was higher in the SCH-STS group (SCH in two or three gestational trimesters) compared to the SCH group. With a tendency for TSH levels to increase as the pregnancy progressed.
Conclusion
SCH during pregnancy is associated with a high incidence of various pregnancy complications, and LT4 therapy that controls serum TSH levels at normal levels throughout pregnancy can reduce these risks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center for Clinical Medical Sciences, The Fourth Hospital of Shijiazhuang, Shijiazhuang, China.
- School of Public Health, Hebei Medical University, Shijiazhuang, China.
- Department of Clinical Laboratory, The Fourth Hospital of Shijiazhuang, Shijiazhuang, China.
- Department of Medicine, The Fourth Hospital of Shijiazhuang, Shijiazhuang, China.
- Department of Gynecology, The Fourth Hospital of Shijiazhuang, Shijiazhuang, China.
Zitieren
APA
Zhou, Y., Wang, Y., Yu, T., Li, Y., Mi, M., Su, J., & Ge, J. (2025). Subclinical hypothyroidism during pregnancy and the impact of levothyroxine therapy on pregnancy outcomes in women. PeerJ. https://doi.org/10.7717/peerj.19343
Vancouver
Zhou Y, Wang Y, Yu T, Li Y, Mi M, Su J, et al. Subclinical hypothyroidism during pregnancy and the impact of levothyroxine therapy on pregnancy outcomes in women. PeerJ. 2025. doi:10.7717/peerj.19343
BibTeX
@article{Zhou2025,
author = {Zhou, Yutian and Wang, Yi and Yu, Tianxiao and Li, Yuan and Mi, Meiyan and Su, Jianqiang and Ge, Jun},
title = {Subclinical hypothyroidism during pregnancy and the impact of levothyroxine therapy on pregnancy outcomes in women},
journal = {PeerJ},
year = {2025},
doi = {10.7717/peerj.19343}
}
EUVIMED